World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
82
Citations
35688
World Ranking
1452
National Ranking
683

M. Eileen Dolan publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where M. Eileen Dolan sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 297 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

M. Eileen Dolan D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where M. Eileen Dolan sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 82 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

M. Eileen Dolan is affiliated with the University of Chicago in the United States and has conducted research primarily in the field of Medicine, with a focus on Oncology, Molecular Biology, Sensory Systems, Pulmonary and Respiratory Medicine, and Cognitive Neuroscience. Their work covers multiple subfields, reflecting a multidisciplinary approach to biomedical research.

Their recent publications include studies addressing various aspects of chemotherapy-related side effects, cellular sensitivity to treatment, and neurological impacts. Selected recent papers are:

  • "Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy," 2023, Journal of Clinical Oncology
  • "Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy," 2022, Cancer Medicine
  • "Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations," 2021, Human Molecular Genetics
  • "Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments," 2022, Ear and Hearing
  • "Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine," 2021, Clinical and Translational Science

The main topics of work include:

  • Hearing, Cochlea, Tinnitus, Genetics
  • Cancer Treatment and Pharmacology
  • Ear and Head Tumors
  • Hearing Loss and Rehabilitation
  • Vestibular and auditory disorders
  • Brain Metastases and Treatment
  • Cancer-related cognitive impairment studies

Frequent co-authors associated with their research include:

  • Lois B. Travis
  • Chunkit Fung
  • Paul C. Dinh
  • Lawrence H. Einhorn
  • Darren R. Feldman

M. Eileen Dolan has published multiple papers in several scientific journals, with the most frequent publication venues including:

  • Journal of Clinical Oncology
  • Cancer Epidemiology Biomarkers & Prevention
  • Cancer Medicine
  • Clinical Cancer Research
  • The Journal of STEM Outreach

Best Publications

  • The Gene Ontology (GO) database and informatics resource.

    Harris Ma;Clark J;Ireland A;Lomax J

  • The Gene Ontology resource: enriching a GOld mine

    Seth Carbon;Eric Douglass;Benjamin M Good

  • Human polymorphism at microRNAs and microRNA target sites.

    Liuqing Yang;Chunru Lin;Chunyu Jin;Joy C. Yang

  • Molecular mechanisms of resistance and toxicity associated with platinating agents.

    Cara A. Rabik;M. Eileen Dolan

  • Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS.

    Dan L. Nicolae;Eric R. Gamazon;Wei Zhang;Shiwei Duan

  • High-throughput discovery of novel developmental phenotypes

    Mary E. Dickinson;Ann M. Flenniken;Xiao Ji;Lydia Teboul

  • Gene ontology annotations and resources

    Blake Ja;Dolan M;Drabkin H

  • The Gene Ontology project in 2008

    Midori A Harris;Jennifer I. Deegan;Amelia Ireland;Jane Lomax

  • Testicular Cancer Survivorship: Research Strategies and Recommendations

    Lois B. Travis;Clair Beard;James M. Allan;Alv A. Dahl

  • Mouse Genome Database (MGD): Knowledgebase for mouse-human comparative biology.

    Judith A Blake;Richard Baldarelli;James A Kadin;Joel E Richardson

  • Mouse models of human AML accurately predict chemotherapy response

    Johannes Zuber;Ina Radtke;Timothy S. Pardee;Zhen Zhao

  • Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy

    Peter H. O'Donnell;M. Eileen Dolan

  • Effect of O6-Benzylguanine Analogues on Sensitivity of Human Tumor Cells to the Cytotoxic Effects of Alkylating Agents

    M. Eileen Dolan;R. Brian Mitchell;Christine Mummert;Robert C. Moschel

  • The Gene Ontology: Enhancements for 2011

    J. A. Blake;M. Dolan;H. Drabkin;D. P. Hill

  • Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics

    Federico Innocenti;Deanna L. Kroetz;Erin Schuetz;M. Eileen Dolan

  • Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

    Barthelemy Diouf;Kristine R. Crews;Glen Lew;Deqing Pei

  • Phase I Trial of Carmustine Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma

    Jennifer A. Quinn;Annick Desjardins;Jon David Weingart;Henry Brem

  • MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11

    Jessica Bockhorn;Rachel Dalton;Chika Nwachukwu;Simo Huang

  • Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

    Everett E. Vokes;Merrill S. Kies;Daniel J. Haraf;Kerstin Stenson

  • SCAN: SNP and copy number annotation

    Eric R. Gamazon;Wei Zhang;Anuar Konkashbaev;Shiwei Duan

Frequent Co-Authors

Anthony E. Pegg
Anthony E. Pegg Pennsylvania State University
Nancy J. Cox
Nancy J. Cox Vanderbilt University Medical Center
Eric R. Gamazon
Eric R. Gamazon Vanderbilt University Medical Center
Shiwei Duan
Shiwei Duan Ningbo University
Mark J. Ratain
Mark J. Ratain University of Chicago
Henry S. Friedman
Henry S. Friedman Duke University
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Lawrence H. Einhorn
Lawrence H. Einhorn Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying genetics in the USA opens many doors to additional online degrees and healthcare careers. For those interested in healthcare administration, pursuing an accelerated healthcare administration degree lets you gain leadership skills and advance your career quickly. You can also consider the overall healthcare administration degree cost to find affordable options that fit your budget.

If you prefer clinical work, researching the easiest nursing schools to get into can streamline your journey into nursing. This provides a solid foundation in patient care and can complement genetics expertise.

Beyond clinical roles, genetics graduates might explore technology-driven healthcare jobs, such as by earning a medical coder certification. This credential equips you for in-demand administrative roles, connecting genetics knowledge with medical data management.

Each of these pathways offers flexible, online learning options and career advancement in healthcare, whether your interests are in management, clinical practice, or specialized support roles.

Best Scientists Citing M. Eileen Dolan

Trending Scientists

Recently Published Articles